ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial

ASP5094 是一种针对整合素 α-9 的人源化单克隆抗体，对对甲氨蝶呤有耐药性的类风湿性关节炎患者没有疗效：一项 2a 期、随机、双盲、安慰剂对照试验的结果